CX-024414 for Covid-19 immunisation: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 385 adverse event reports in the FDA FAERS database where CX-024414 was used for Covid-19 immunisation.
Most Reported Side Effects for CX-024414
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Fatigue | 117 | 16.9% | 4 | 32 |
| Pyrexia | 89 | 12.8% | 0 | 26 |
| Headache | 87 | 12.6% | 4 | 19 |
| Pain | 81 | 11.7% | 0 | 18 |
| Nausea | 69 | 10.0% | 2 | 10 |
| Chills | 64 | 9.2% | 0 | 18 |
| Pain in extremity | 59 | 8.5% | 0 | 13 |
| Arthralgia | 49 | 7.1% | 0 | 11 |
| Diarrhoea | 45 | 6.5% | 3 | 12 |
| Malaise | 40 | 5.8% | 2 | 9 |
| Asthenia | 39 | 5.6% | 2 | 19 |
| Rash | 38 | 5.5% | 0 | 18 |
| Drug ineffective | 36 | 5.2% | 1 | 12 |
| Dyspnoea | 36 | 5.2% | 3 | 17 |
| Pruritus | 36 | 5.2% | 0 | 8 |
Other Indications for CX-024414
Product used for unknown indication (91)
Covid-19 prophylaxis (50)
Immunisation (24)
Covid-19 (22)
Prophylaxis (13)
Other Drugs Used for Covid-19 immunisation
TOZINAMERAN (4,585)
COVID-19 VACCINE NOS (1,641)
ELASOMERAN (1,258)
AZD-1222 (1,166)
COVID-19 VACCINE (305)
AD26.COV2.S (190)
NIRMATRELVIR\RITONAVIR (108)
RAXTOZINAMERAN (43)
BRETOVAMERAN (39)
UNSPECIFIED INGREDIENT (25)